Identification of Prognostic Immunophenotypes at First Diagnosis in Patients with Acute Myeloid Leukemia (AML) By a Standardized Multicolor Flow Cytometry (MFC) Panel Originally Designed to Detect Measurable Residual Disease (MRD) at Follow-upMaximilian Alexander Röhnert, Uta Oelschlägel, Malte von Bonin et al.|Blood|2020Cited by 2
P538: FAST-TRACK MEASURABLE RESIDUAL DISEASE DETECTION BY MULTIPARAMETRIC FLOW CYTOMETRY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATIONMaximilian Roehnert, Uta Oelschlaegel, Christoph Roellig et al.|HemaSphere|2023Cited by 0